<?xml version="1.0" encoding="UTF-8"?>
<fig id="F3" position="float" class="fig">
 <label class="label">Figure 3</label>
 <caption class="caption">
  <p class="p">Physiological functions of CLA and HYA. CLA and HYA are produced from linoleic acid by intestinal bacteria. 
   <italic class="italic">c</italic>9,
   <italic class="italic">t</italic>11-CLA ameliorates insulin sensitivity and prevents atherosclerosis, 
   <italic class="italic">t</italic>10,
   <italic class="italic">c</italic>12-CLA deteriorates insulin sensitivity and promotes atherosclerosis, and 
   <italic class="italic">t</italic>9,
   <italic class="italic">t</italic>11-CLA prevents atherosclerosis. HYA enhances intestinal barrier function by increasing occludin expression and inhibiting intestinal inflammation in a GPR40-dependent manner. HYA inhibits atopic dermatitis by increasing claudin-1 expression and enhancing skin barrier function. HYA also inhibits gastric 
   <italic class="italic">Helicobacter</italic> infections by blocking the bacterial futalosine pathways.
  </p>
 </caption>
 <graphic xlink:href="fnut-06-00036-g0003" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
